141 related articles for article (PubMed ID: 32529269)
1. CD36 Expression Is Associated with Cancer Aggressiveness and Energy Source in Esophageal Squamous Cell Carcinoma.
Yoshida T; Yokobori T; Saito H; Kuriyama K; Kumakura Y; Honjo H; Hara K; Sakai M; Miyazaki T; Obinata H; Erkhem-Ochir B; Gombodorj N; Sohda M; Saeki H; Kuwano H; Shirabe K
Ann Surg Oncol; 2021 Feb; 28(2):1217-1227. PubMed ID: 32529269
[TBL] [Abstract][Full Text] [Related]
2. Cripto-1 acts as a functional marker of cancer stem-like cells and predicts prognosis of the patients in esophageal squamous cell carcinoma.
Liu Q; Cui X; Yu X; Bian BS; Qian F; Hu XG; Ji CD; Yang L; Ren Y; Cui W; Zhang X; Zhang P; Wang JM; Cui YH; Bian XW
Mol Cancer; 2017 Apr; 16(1):81. PubMed ID: 28431580
[TBL] [Abstract][Full Text] [Related]
3. Long noncoding RNA, tissue differentiation-inducing nonprotein coding RNA is upregulated and promotes development of esophageal squamous cell carcinoma.
Xu Y; Qiu M; Chen Y; Wang J; Xia W; Mao Q; Yang L; Li M; Jiang F; Xu L; Yin R
Dis Esophagus; 2016 Nov; 29(8):950-958. PubMed ID: 26833746
[TBL] [Abstract][Full Text] [Related]
4. RACK1 predicts poor prognosis and regulates progression of esophageal squamous cell carcinoma through its epithelial-mesenchymal transition.
Wang N; Liu F; Cao F; Jia Y; Wang J; Ma W; Tan B; Wang K; Song Q; Cheng Y
Cancer Biol Ther; 2015; 16(4):528-40. PubMed ID: 25719728
[TBL] [Abstract][Full Text] [Related]
5. Expression and role of anion exchanger 1 in esophageal squamous cell carcinoma.
Shiozaki A; Kudou M; Ichikawa D; Shimizu H; Arita T; Kosuga T; Konishi H; Komatsu S; Fujiwara H; Okamoto K; Kishimoto M; Marunaka Y; Otsuji E
Oncotarget; 2017 Mar; 8(11):17921-17935. PubMed ID: 28160546
[TBL] [Abstract][Full Text] [Related]
6. RNF113A promotes the proliferation, migration and invasion, and is associated with a poor prognosis of esophageal squamous cell carcinoma.
Wang L; Hou Z; Hasim A; Abuduerheman A; Zhang H; Niyaz M; Awut I; Upur H; Sheyhidin I
Int J Oncol; 2018 Mar; 52(3):861-871. PubMed ID: 29393393
[TBL] [Abstract][Full Text] [Related]
7. TGFBI Expression in Cancer Stromal Cells is Associated with Poor Prognosis and Hematogenous Recurrence in Esophageal Squamous Cell Carcinoma.
Ozawa D; Yokobori T; Sohda M; Sakai M; Hara K; Honjo H; Kato H; Miyazaki T; Kuwano H
Ann Surg Oncol; 2016 Jan; 23(1):282-9. PubMed ID: 25448803
[TBL] [Abstract][Full Text] [Related]
8. Overexpression of U three protein 14a (UTP14a) is associated with poor prognosis of esophageal squamous cell carcinoma.
Li KK; Mao CY; Zhang JG; Ma Q; Wang YJ; Liu XH; Bao T; Guo W
Thorac Cancer; 2019 Nov; 10(11):2071-2080. PubMed ID: 31496055
[TBL] [Abstract][Full Text] [Related]
9. Overexpression of miR-191 Predicts Poor Prognosis and Promotes Proliferation and Invasion in Esophageal Squamous Cell Carcinoma.
Gao X; Xie Z; Wang Z; Cheng K; Liang K; Song Z
Yonsei Med J; 2017 Nov; 58(6):1101-1110. PubMed ID: 29047233
[TBL] [Abstract][Full Text] [Related]
10. Solute Carrier Family 39 Member 6 Gene Promotes Aggressiveness of Esophageal Carcinoma Cells by Increasing Intracellular Levels of Zinc, Activating Phosphatidylinositol 3-Kinase Signaling, and Up-regulating Genes That Regulate Metastasis.
Cheng X; Wei L; Huang X; Zheng J; Shao M; Feng T; Li J; Han Y; Tan W; Tan W; Lin D; Wu C
Gastroenterology; 2017 Jun; 152(8):1985-1997.e12. PubMed ID: 28209530
[TBL] [Abstract][Full Text] [Related]
11. Plasma miR-185 is decreased in patients with esophageal squamous cell carcinoma and might suppress tumor migration and invasion by targeting RAGE.
Jing R; Chen W; Wang H; Ju S; Cong H; Sun B; Jin Q; Chu S; Xu L; Cui M
Am J Physiol Gastrointest Liver Physiol; 2015 Nov; 309(9):G719-29. PubMed ID: 26316588
[TBL] [Abstract][Full Text] [Related]
12. Functional Analysis and Clinical Significance of Chloride Channel 2 Expression in Esophageal Squamous Cell Carcinoma.
Mitsuda M; Shiozaki A; Kudou M; Shimizu H; Arita T; Kosuga T; Konishi H; Komatsu S; Kubota T; Fujiwara H; Okamoto K; Kishimoto M; Konishi E; Otsuji E
Ann Surg Oncol; 2021 Sep; 28(9):5384-5397. PubMed ID: 33565032
[TBL] [Abstract][Full Text] [Related]
13. Musashi1, a potential prognostic marker in esophageal squamous cell carcinoma.
Qin G; Lian J; Yue D; Chen X; Nan S; Qi Y; Li B; Cui G; Li X; Zhao S; Zhang Y
Oncol Rep; 2017 Sep; 38(3):1724-1732. PubMed ID: 28713964
[TBL] [Abstract][Full Text] [Related]
14. Expression and clinical significance of REPS2 in human esophageal squamous cell carcinoma.
Zhang H; Duan CJ; Zhang H; Cheng YD; Zhang CF
Asian Pac J Cancer Prev; 2013; 14(5):2851-7. PubMed ID: 23803043
[TBL] [Abstract][Full Text] [Related]
15. The tumor-suppressive role of BATF2 in esophageal squamous cell carcinoma.
Han T; Wang Z; Yang Y; Shu T; Li W; Liu D; Li P; Qi R; Ren Y; Li L; Liu H; Zhang S; Zhang L
Oncol Rep; 2015 Sep; 34(3):1353-60. PubMed ID: 26135942
[TBL] [Abstract][Full Text] [Related]
16. High expression of TACC3 in esophageal squamous cell carcinoma correlates with poor prognosis.
Huang ZL; Lin ZR; Xiao YR; Cao X; Zhu LC; Zeng MS; Zhong Q; Wen ZS
Oncotarget; 2015 Mar; 6(9):6850-61. PubMed ID: 25760075
[TBL] [Abstract][Full Text] [Related]
17. Long noncoding RNA H19 is up-regulated in esophageal squamous cell carcinoma and promotes cell proliferation and metastasis.
Tan D; Wu Y; Hu L; He P; Xiong G; Bai Y; Yang K
Dis Esophagus; 2017 Jan; 30(1):1-9. PubMed ID: 27247022
[TBL] [Abstract][Full Text] [Related]
18. Circ-TTC17 Promotes Proliferation and Migration of Esophageal Squamous Cell Carcinoma.
Wang Q; Zhang Q; Sun H; Tang W; Yang L; Xu Z; Liu Z; Jin H; Cao X
Dig Dis Sci; 2019 Mar; 64(3):751-758. PubMed ID: 30519852
[TBL] [Abstract][Full Text] [Related]
19. HERG1 promotes esophageal squamous cell carcinoma growth and metastasis through TXNDC5 by activating the PI3K/AKT pathway.
Wang H; Yang X; Guo Y; Shui L; Li S; Bai Y; Liu Y; Zeng M; Xia J
J Exp Clin Cancer Res; 2019 Jul; 38(1):324. PubMed ID: 31331361
[TBL] [Abstract][Full Text] [Related]
20. Overexpression of SRC-3 promotes esophageal squamous cell carcinoma aggressiveness by enhancing cell growth and invasiveness.
Xu FP; Liu YH; Luo XL; Zhang F; Zhou HY; Ge Y; Liu C; Chen J; Luo DL; Yan LX; Mei P; Xu J; Zhuang HG
Cancer Med; 2016 Dec; 5(12):3500-3511. PubMed ID: 27781415
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]